Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis
Cristina Guarnera, Placido Bramanti, Emanuela Mazzon Experimental Neurology Laboratory, IRCCS Centro Neurolesi “Bonino-Pulejo”, Via Provinciale Palermo, Contrada Casazza, Messina, Italy Abstract: Alemtuzumab is a selective humanized monoclonal antibody directed against the CD52...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-07-01
|
| Series: | Therapeutics and Clinical Risk Management |
| Subjects: | |
| Online Access: | https://www.dovepress.com/alemtuzumab-a-review-of-efficacy-and-risks-in-the-treatment-of-relapsi-peer-reviewed-article-TCRM |